Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Genocea Biosciences Inc. (GNCA)

0.55 0.04 (7.76%)

09-21 16:00

Open:

0.52

Pre. Close:

0.5104

High:

0.55

Low:

0.5051

Volume:

247,996

Market Cap:

48M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.55 - 0.554

0.554 - 0.557

Low:

0.503 - 0.507

0.507 - 0.51

Close:

0.545 - 0.551

0.551 - 0.556

Technical analysis  (as of: 2018-09-21 4:26:59 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 0.71     One year: 0.79

Support:

Support1: 0.49    Support2: 0.41

Resistance:

Resistance1: 0.61    Resistance2: 0.68

Pivot:

0.56

Moving Averages:

MA(5): 0.52     MA(20): 0.57

MA(100): 0.77     MA(250): 0.98

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 21.04     %D(3): 13.15

RSI:

RSI(14): 43.25

52-Week:

High: 5.45  Low: 0.49  Change(%): -89.7

Average Vol(K):

3-Month: 34434  10-Days 32768

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GNCA has closed above bottom band by 46.4%. Bollinger Bands are 25.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-31T04:02:59-04:00
Your Daily Pharma Scoop: Recent IPO And Offerings Review

2018-05-30T03:06:02-04:00
Reader Inquiry: Can Genocea Biosciences Really Pull Off The Makeover?

2018-05-10T14:19:04-04:00
Genocea Biosciences' (GNCA) CEO Chip Clark on Q1 2018 Results - Earnings Call Transcript

2018-05-04T08:00:00-04:00
3 Things In Biotech, May 3: Bristol Bows Out Of IDO, And Two Biotechs Look To Investigate Novel Immunotherapies

2018-03-08T09:20:10-05:00
Premarket Gainers as of 9:05 am (03/08/2018)

2018-03-07T08:00:00-05:00
Your Daily Pharma Scoop: Genocea Surges, Gilead's Biktarvy, GlaxoSmithKline's Vaccine Succeeds In Late-Stage Study

2018-03-06T12:45:05-05:00
Midday Gainers / Losers (3/6/2018)

2018-03-06T09:11:52-05:00
Premarket Gainers as of 9:05 am (03/06/2018)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

86.63

Shares Float (M)

86.45

% Held by Insiders

% Held by Institutions

58.50

Shares Short (K)

1814

Shares Short Prior Month (K)

Stock Financials

EPS

-1.210

EPS Est. Current Year

-1.920

EPS Est. Next Year

-1.110

EPS Est. Next Quarter

-0.370

Forward EPS

-0.730

Book Value (p.s.)

3.510

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-103.5

Return on Equity (ttm)

-292.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.302

Qtrly Earnings Growth

Operating Cash Flow (M)

-42.97

Levered Free Cash Flow (M)

-25.42

Valuation

P/E

-0.45

P/E Growth Ratio

0.08

P/BV

0.16

P/S

P/CF

-1.11

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.